DistantNews
Support us
Hemp Parade in Berlin: Calls for further cannabis legalization
๐Ÿ‡ฉ๐Ÿ‡ช Germany /Culture & Society

Hemp Parade in Berlin: Calls for further cannabis legalization

From Die Zeit · () German

Translated from German, summarized and contextualized by DistantNews.

At a glance

News Sources not specified Ongoing story
  • Around 200 people participated in Berlin's annual Hemp Parade, demanding further legalization of cannabis.
  • Protesters marched from Alexanderplatz to the government district, carrying banners with slogans like "Cannabis is Medicine."
  • The current partial legalization, enacted in April 2024, is considered insufficient by organizers and many participants.

Protesters gathered in Berlin for the annual Hemp Parade, calling for a more comprehensive legalization of cannabis under the motto "Just! Healthy! Enjoy!". Approximately 200 people, according to initial police reports, convened at Alexanderplatz for the demonstration, with organizers anticipating up to 4,000 attendees.

The parade proceeded from Alexanderplatz along the Unter den Linden boulevard towards the government district. Participants carried banners with messages such as "Cannabis is Medicine," "I am High," and "Berlin in a Haze." The planned route included passing by the Ministry of Health and the office of the federal government's drug commissioner, Hendrik Streeck.

The Hemp Parade has been a yearly event in Berlin since 1997. Its organizers advocate for a shift in drug policy, moving away from ideology-driven approaches towards one based on reason. They argue that the current legal framework, which partially legalized cannabis in April 2024, does not go far enough. This partial legalization, implemented by the then-ruling coalition of SPD, Greens, and FDP, permits the cultivation and possession of cannabis within limited scope for adults under specific regulations.

DistantNews Editorial

Originally published by Die Zeit in German. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.